Efalex
Natural health product licensed in Canada
- Other names
- Brain Booster Efalex, Efalex - Brain Booster, Efalex capsules, Efalex for Kids, Efalex for Kids - Brain Booster, Efamol Brain - Brain Booster Efalex, Efamol Brain - Kids Brain Booster Efalex, Kids Brain Booster Efalex
- Licence holder
- Flora Manufacturing & Distributing Ltd
- NPN or DIN-HM
- 80002598
- Status
- Active licence
- Licence date
- 5 January 2007
- Revision date
- 24 August 2022
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Thunnus sp. Source : Huile du corps de thon Potency : 12 mg Gamma-Linolenic Acid | Not specified | Not calculated |
| Thunnus sp. Source : Huile du corps de thon Potency : 60 mg Docosahexaenoic acid | Not specified | Not calculated |
| Thunnus sp. Source : Huile du corps de thon Potency : 100 mg Linoleic acid | 365.7 mg | Not calculated |
Non-medicinal ingredients
Gélatine, Huile de thym, alpha-tocophérol, simethicone, Glycérine, Solution de sorbitol, Huile de soja
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 8 Capsule | 1 Tous les jours |
| Enfants | minimum: 5 years | 8 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
May help to relieve some symptoms of learning/behaviour disorders including dyslexia, dyspraxia and attention deficit hyperactivity disorder. Maintains and supports brain and eye functions including learning ability, concentration, coordination and nerve transmission.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80002598
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2022. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.